Using health technology assessment across the spectrum of health care delivery—from services to biotechnologies—could curb some of the $1 trillion in spending on defects in value in the US. However, ...
The Centers for Medicare and Medicaid Services (CMS) can now negotiate the prices of a set of drugs that represent significant Medicare expenditures. The long-term success of negotiations will depend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results